Drug Eluting Stent definition

Drug Eluting Stent means a Stent that elutes or otherwise delivers one or more drugs or pharmaceutical compositions.
Drug Eluting Stent means a Stent that elutes or otherwise delivers one or more drugs or pharmaceutical compositions for the treatment of coronary artery disease.

Examples of Drug Eluting Stent in a sentence

  • Short-Term Versus Long-Term Dual Antiplatelet Therapy After Drug- Eluting Stent Implantation in Elderly Patients: A Meta-Analysis of Individual Participant Data From 6 Randomized Trials.

  • Therefore, in this final rule, we are creating new DRG 525 (Percutaneous Cardiovascular Procedure with, Drug-Eluting Stent with AMI) and new DRG 527 (Percutaneous Cardioascular Procedure with Drug- Eluting Stent without AMI).

  • During 2012 the sites solvent usage in absolute terms increased due to increases in production levels in Drug Eluting Stent manufacturing.

  • Development of a Novel Drug Eluting Stent with Improved Efficacy, Safety and BiocompatibilityLouisiana State University Health Sciences Center-Shreveport/ Department of Pharmacology, Toxicology and NeuroscienceTammy R.

  • Cartons of the stents used approved by FDA/CE/DCGI only, 3.clinical photographs with AM/VAMCO* 156 245 Cardiology Cardiology Vertebral Angioplasty (Drug Eluting Stent) 65000 ECG, 2D ECHO, CAG stills showing blocks & Reports, HBA1c report, clinical photographs with AM/VAMCO 1.

  • Cartons of the stents used approved by FDA/CE/DCGI only, 3.clinical photographs with AM/VAMCO* 155 245 Cardiology Cardiology Vertebral Angioplasty (Drug Eluting Stent) 65000 ECG, 2D ECHO, CAG stills showing blocks & Reports, HBA1c report,clinical photographs with AM/VAMCO 1.Angioplasty stills showing stents & post Stent flow,2.

  • BMS or DES PIs • Ori Ben Yehuda, M.D., CRF • Simon Eccleshall, M.D ., Norfolk & Norwich Hospital 11 Coronary Drug Eluting Stent Development Strategy Develop two s trategic p artnerships to attach MicroNet to clinically proven FDA and/or CE marked DES .

  • Contract award split: Drug Eluting Stent Medtronic £113,850; Boston Scientific £226,021.

  • Cartons of the stents used approved by FDA/CE/DCGI only, 3.clinical photographs with AM/VAMCO* 150 240 Cardiology Cardiology PTCA - one stent (Drug Eluting Stent , elective) 65000 ECG, 2D ECHO, CAG stills showing blocks & Reports, HBA1c report,clinical photographs with AM/VAMCO 1.Angioplasty stills showing stents & post Stent flow,2.

  • Richmond Academy of Medicine, Invited Lecturer: Horsley Lecture; Percutaneous Coronary Intervention 2007: Implications of the Drug Eluting Stent Controversy.

Related to Drug Eluting Stent

  • Drug outlet means a pharmacy, nursing home, shelter home, convalescent home, extended care facility, drug abuse treatment center, penal institution, hospital, family planning clinic, student health center, retail store, wholesaler, manufacturer, mail-order vendor or other establishment with facilities located within or out of this state that is engaged in dispensing, delivery or distribution of drugs within this state.

  • Therapeutic diet means meals served that are soft, low-fat, low-sodium or controlled calorie.

  • Drug addiction means a disease characterized by a

  • COVID-19 symptoms means fever of 100.4 degrees Fahrenheit or higher, chills, cough, shortness of breath or difficulty breathing, fatigue, muscle or body aches, headache, new loss of taste or smell, sore throat, congestion or runny nose, nausea or vomiting, or diarrhea, unless a licensed health care professional determines the person’s symptoms were caused by a known condition other than COVID-19.

  • Radiopharmaceutical quality assurance means, but is not limited to, the performance of appropriate chemical, biological, and physical tests on potential radiopharmaceuticals and the interpretation of the resulting data to determine their suitability for use in humans and animals, including internal test assessment, authentication of product history, and the keeping of proper records.

  • Clinical nurse specialist means a registered nurse with relevant post-basic qualifications and 12 months’ experience working in the clinical area of his/her specified post-basic qualification, or a minimum of four years’ post-basic registration experience, including three years’ experience in the relevant specialist field and who satisfies the local criteria.

  • Pivotal Clinical Trial means a human clinical trial in any country that is prospectively designed to generate data intended to satisfy the requirements of 21 C.F.R. § 312.21(c) (as amended) in the U.S. or a similar clinical study prescribed by a Regulatory Authority from another country, from time to time, pursuant to Applicable Law.

  • Drug abuse means any pattern of pathological use of drugs that causes impairment in social or occupational functioning, or that produces physiological dependency evidenced by physical tolerance or by physical symptoms when it is withdrawn.

  • Clinical laboratory means a facility for the microbiological, serological, chemical, hematological, radiobioassay, cytological, immunohematological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of a disease or assessment of a medical condition.

  • Marihuana-infused product means a topical formulation, tincture, beverage, edible substance, or similar product containing marihuana and other ingredients and that is intended for human consumption.

  • Therapeutic Product means a health product categorised as a therapeutic product in the First Schedule to the Act;

  • Active Pharmaceutical Ingredient or “API” shall mean one or more of the following active pharmaceutical ingredients: tenofovir alafenamide (“TAF”), tenofovir disoproxil fumarate (“TDF”), elvitegravir (“EVG”), and cobicistat (“COBI”).

  • Drug test means a test designed to detect the illegal use of a controlled substance.

  • Phase 4 Clinical Trial means a Clinical Trial of a Product conducted after Regulatory Approval of such Product has been obtained from an appropriate Regulatory Authority, which trial is (a) conducted voluntarily by a Party to enhance marketing or scientific knowledge of the Product, or (b) conducted due to a request or requirement of a Regulatory Authority.

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.

  • Traffic control device means a flagger, sign, signal, marking, or other device used to regulate, warn or guide traffic, placed on, over, or adjacent to a street, highway, private road open to public travel, pedestrian facility, or shared-use path by authority of a public agency or official having jurisdiction, or, in the case of a private road open to public travel, by authority of the private owner or private official having jurisdiction.

  • Alcohol Screening Device (ASD) means a breath or saliva device, other than an Evidential Breath Testing Device (EBT), that is approved by the National Highway Traffic Safety Administration and placed on its Conforming Products List for such devices.

  • Step therapy protocol means a protocol or program that establishes the specific

  • Radiopharmaceutical service means, but is not limited to, the procurement, storage, handling preparation, labeling, quality assurance testing, dispensing, delivery, recordkeeping, and disposal of radiopharmaceuticals and other drugs.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Edible cannabis product means cannabis product that is intended to be used, in whole or in part, for human consumption, including, but not limited to, chewing gum, but excluding products set forth in Division 15 (commencing with Section 32501) of the Food and Agricultural Code. An edible cannabis product is not considered food, as defined by Section 109935 of the Health and Safety Code, or a drug, as defined by Section 109925 of the Health and Safety Code.

  • Autism spectrum disorder means a neuro-developmental condition typically appearing in the first three years of life that significantly affects a person's ability to communicate, understand relationships and relate to others, and is frequently associated with unusual or stereotypical rituals or behaviours.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • COVID-19 Pandemic means the epidemic, pandemic or disease outbreak associated with COVID-19.

  • Therapeutic school means a residential group living facility: